The expression was upregulated under the RA state, whereas it was decreased after triple DMARD treatment (methotrexate, sulfasalazine, and hydroxychloroquine), suggesting that SLAMF8 is involved in the pathogenies of RA. This evidence concerns the gene SLAMF8 and rheumatoid arthritis.